Trial Profile
Phase 1 trial of brilacidin [PMX 30063] in patients with Hidradenitis-suppurativa
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Feb 2017
Price :
$35
*
At a glance
- Drugs Brilacidin (Primary)
- Indications Hidradenitis suppurativa
- Focus Adverse reactions
- 24 Feb 2017 New trial record